Global Clinical Trial Supply Services 麻豆原创 Research Report 2023

Publication ID:

PB503248054

Publication Date:

March 8, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A safe clinical trial presupposes a robust supply chain management of the study drugs, consistent with various regional and global regulations and available infrastructures.
Highlights
The global Clinical Trial Supply Services market was valued at US$ 2210.6 million in 2022 and is anticipated to reach US$ 3566.8 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Safe clinical trials are premised on strong supply chain management of the investigational drug, in accordance with regional and global regulations, and in line with local production and development realities. Clinical trial consumable management is critical to avoid overproduction, inventory expiration, and oversupply.As the cost of drug development continues to rise, the supply of clinical trials is becoming ever more important.In addition, strict operational requirements for the implementation of a variety of biopharmaceutical products into clinical trials require constant reform of clinical trial supply strategies.This also requires the integration of multiple third party vendors at all stages of clinical development. Global Clinical Trial Supplies key players include Thermo Fisher Scientific, Catalent Pharma Solutions, Almac Group, Parexel International, UDG Healthcare etc. China top five manufacturers hold a Production Share over 70%. North America accounts for the most Sales 麻豆原创 Share, which have a share over 50%, followed by Europe. In terms of product, Supply Chain Management is the largest segment, with a 麻豆原创 Share over 35%. And in terms of application, the largest Application is Clinical Phase iii.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supply Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supply Services.
The Clinical Trial Supply Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trial Supply Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Supply Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Parexel International
ALMAC Group
Catalent Pharma Solutions
Piramal Pharma Solutions
Shertech Manufacturing
Thermo Fisher Scientific
PCI Services
Patheon, Inc.
Sharp Packaging Services
Biocair
Movianto
Klifo A/S.
Segment by Type
Manufacturing
Packaging and Labeling
Logistics and Distribution
Segment by Application
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Dermatology
Blood Disorders
Infectious Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Supply Services companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Clinical Trial Supply Services 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Manufacturing
1.2.3 Packaging and Labeling
1.2.4 Logistics and Distribution
1.3 麻豆原创 by Application
1.3.1 Global Clinical Trial Supply Services 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Respiratory Diseases
1.3.5 CNS And Mental Disorders
1.3.6 Dermatology
1.3.7 Blood Disorders
1.3.8 Infectious Diseases
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Supply Services 麻豆原创 Perspective (2018-2029)
2.2 Clinical Trial Supply Services Growth Trends by Region
2.2.1 Global Clinical Trial Supply Services 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Supply Services Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Clinical Trial Supply Services Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Clinical Trial Supply Services 麻豆原创 Dynamics
2.3.1 Clinical Trial Supply Services Industry Trends
2.3.2 Clinical Trial Supply Services 麻豆原创 Drivers
2.3.3 Clinical Trial Supply Services 麻豆原创 Challenges
2.3.4 Clinical Trial Supply Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Supply Services Players by Revenue
3.1.1 Global Top Clinical Trial Supply Services Players by Revenue (2018-2023)
3.1.2 Global Clinical Trial Supply Services Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Clinical Trial Supply Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Supply Services Revenue
3.4 Global Clinical Trial Supply Services 麻豆原创 Concentration Ratio
3.4.1 Global Clinical Trial Supply Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Supply Services Revenue in 2022
3.5 Clinical Trial Supply Services Key Players Head office and Area Served
3.6 Key Players Clinical Trial Supply Services Product Solution and Service
3.7 Date of Enter into Clinical Trial Supply Services 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Supply Services Breakdown Data by Type
4.1 Global Clinical Trial Supply Services Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Clinical Trial Supply Services Forecasted 麻豆原创 Size by Type (2024-2029)
5 Clinical Trial Supply Services Breakdown Data by Application
5.1 Global Clinical Trial Supply Services Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Clinical Trial Supply Services Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Supply Services 麻豆原创 Size (2018-2029)
6.2 North America Clinical Trial Supply Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clinical Trial Supply Services 麻豆原创 Size by Country (2018-2023)
6.4 North America Clinical Trial Supply Services 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Supply Services 麻豆原创 Size (2018-2029)
7.2 Europe Clinical Trial Supply Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clinical Trial Supply Services 麻豆原创 Size by Country (2018-2023)
7.4 Europe Clinical Trial Supply Services 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Supply Services 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Clinical Trial Supply Services 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clinical Trial Supply Services 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trial Supply Services 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Supply Services 麻豆原创 Size (2018-2029)
9.2 Latin America Clinical Trial Supply Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clinical Trial Supply Services 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Clinical Trial Supply Services 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trial Supply Services 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Parexel International
11.1.1 Parexel International Company Detail
11.1.2 Parexel International Business Overview
11.1.3 Parexel International Clinical Trial Supply Services Introduction
11.1.4 Parexel International Revenue in Clinical Trial Supply Services Business (2018-2023)
11.1.5 Parexel International Recent Development
11.2 ALMAC Group
11.2.1 ALMAC Group Company Detail
11.2.2 ALMAC Group Business Overview
11.2.3 ALMAC Group Clinical Trial Supply Services Introduction
11.2.4 ALMAC Group Revenue in Clinical Trial Supply Services Business (2018-2023)
11.2.5 ALMAC Group Recent Development
11.3 Catalent Pharma Solutions
11.3.1 Catalent Pharma Solutions Company Detail
11.3.2 Catalent Pharma Solutions Business Overview
11.3.3 Catalent Pharma Solutions Clinical Trial Supply Services Introduction
11.3.4 Catalent Pharma Solutions Revenue in Clinical Trial Supply Services Business (2018-2023)
11.3.5 Catalent Pharma Solutions Recent Development
11.4 Piramal Pharma Solutions
11.4.1 Piramal Pharma Solutions Company Detail
11.4.2 Piramal Pharma Solutions Business Overview
11.4.3 Piramal Pharma Solutions Clinical Trial Supply Services Introduction
11.4.4 Piramal Pharma Solutions Revenue in Clinical Trial Supply Services Business (2018-2023)
11.4.5 Piramal Pharma Solutions Recent Development
11.5 Shertech Manufacturing
11.5.1 Shertech Manufacturing Company Detail
11.5.2 Shertech Manufacturing Business Overview
11.5.3 Shertech Manufacturing Clinical Trial Supply Services Introduction
11.5.4 Shertech Manufacturing Revenue in Clinical Trial Supply Services Business (2018-2023)
11.5.5 Shertech Manufacturing Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Clinical Trial Supply Services Introduction
11.6.4 Thermo Fisher Scientific Revenue in Clinical Trial Supply Services Business (2018-2023)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 PCI Services
11.7.1 PCI Services Company Detail
11.7.2 PCI Services Business Overview
11.7.3 PCI Services Clinical Trial Supply Services Introduction
11.7.4 PCI Services Revenue in Clinical Trial Supply Services Business (2018-2023)
11.7.5 PCI Services Recent Development
11.8 Patheon, Inc.
11.8.1 Patheon, Inc. Company Detail
11.8.2 Patheon, Inc. Business Overview
11.8.3 Patheon, Inc. Clinical Trial Supply Services Introduction
11.8.4 Patheon, Inc. Revenue in Clinical Trial Supply Services Business (2018-2023)
11.8.5 Patheon, Inc. Recent Development
11.9 Sharp Packaging Services
11.9.1 Sharp Packaging Services Company Detail
11.9.2 Sharp Packaging Services Business Overview
11.9.3 Sharp Packaging Services Clinical Trial Supply Services Introduction
11.9.4 Sharp Packaging Services Revenue in Clinical Trial Supply Services Business (2018-2023)
11.9.5 Sharp Packaging Services Recent Development
11.10 Biocair
11.10.1 Biocair Company Detail
11.10.2 Biocair Business Overview
11.10.3 Biocair Clinical Trial Supply Services Introduction
11.10.4 Biocair Revenue in Clinical Trial Supply Services Business (2018-2023)
11.10.5 Biocair Recent Development
11.11 Movianto
11.11.1 Movianto Company Detail
11.11.2 Movianto Business Overview
11.11.3 Movianto Clinical Trial Supply Services Introduction
11.11.4 Movianto Revenue in Clinical Trial Supply Services Business (2018-2023)
11.11.5 Movianto Recent Development
11.12 Klifo A/S.
11.12.1 Klifo A/S. Company Detail
11.12.2 Klifo A/S. Business Overview
11.12.3 Klifo A/S. Clinical Trial Supply Services Introduction
11.12.4 Klifo A/S. Revenue in Clinical Trial Supply Services Business (2018-2023)
11.12.5 Klifo A/S. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Parexel International
ALMAC Group
Catalent Pharma Solutions
Piramal Pharma Solutions
Shertech Manufacturing
Thermo Fisher Scientific
PCI Services
Patheon, Inc.
Sharp Packaging Services
Biocair
Movianto
Klifo A/S.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.